Cui W, Xuan T, Liao T, Wang Y
Front Oncol. 2024; 14:1410110.
PMID: 39169938
PMC: 11335555.
DOI: 10.3389/fonc.2024.1410110.
Li Z, Tian J, Chu Y, Zhu H, Wang J, Huang J
J Bone Oncol. 2023; 43:100512.
PMID: 38021073
PMC: 10665705.
DOI: 10.1016/j.jbo.2023.100512.
Rezaeian A, Inuzuka H, Wei W
Adv Protein Chem Struct Biol. 2023; 135:179-201.
PMID: 37061331
PMC: 10976432.
DOI: 10.1016/bs.apcsb.2022.11.009.
Li H, Hu P, Zou Y, Yuan L, Xu Y, Zhang X
Front Oncol. 2023; 13:1071415.
PMID: 36798821
PMC: 9928209.
DOI: 10.3389/fonc.2023.1071415.
Ovrebo J, Ma Y, Edgar B
Bioessays. 2022; 44(11):e2200150.
PMID: 36222263
PMC: 10193172.
DOI: 10.1002/bies.202200150.
Molecular Mechanism of Tanshinone against Prostate Cancer.
Li W, Huang T, Xu S, Che B, Yu Y, Zhang W
Molecules. 2022; 27(17).
PMID: 36080361
PMC: 9457553.
DOI: 10.3390/molecules27175594.
A manzamine-derived compound as a potential therapeutic agent for glioma by inducing apoptosis and cell cycle arrest.
Lin Y, Huang C, Shen Y, Wei K, Chuang C, Hsu P
Am J Cancer Res. 2022; 12(4):1740-1751.
PMID: 35530272
PMC: 9077074.
Cyclin-dependent kinase 4 expression alters the number of keratinocyte stem cells in the mouse hair follicle.
Kim S, Rodriguez L, Macias E, Rodriguez-Puebla M
Cell Biol Int. 2022; 46(5):737-746.
PMID: 35032143
PMC: 9035071.
DOI: 10.1002/cbin.11765.
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer.
Portman N, Chen J, Lim E
Front Oncol. 2021; 11:777867.
PMID: 34804982
PMC: 8596371.
DOI: 10.3389/fonc.2021.777867.
Reciprocal Changes in miRNA Expression with Pigmentation and Decreased Proliferation Induced in Mouse B16F1 Melanoma Cells by L-Tyrosine and 5-Bromo-2'-Deoxyuridine.
Rivera H, Munoz E, Osuna D, Florez M, Carvajal M, Alberto Gomez L
Int J Mol Sci. 2021; 22(4).
PMID: 33562431
PMC: 7914888.
DOI: 10.3390/ijms22041591.
The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.
VanGenderen C, Harkness T, Arnason T
Aging (Albany NY). 2020; 12(15):15818-15855.
PMID: 32805721
PMC: 7467358.
DOI: 10.18632/aging.103792.
Immunomodulation by anticancer cell cycle inhibitors.
Petroni G, Formenti S, Chen-Kiang S, Galluzzi L
Nat Rev Immunol. 2020; 20(11):669-679.
PMID: 32346095
PMC: 7584736.
DOI: 10.1038/s41577-020-0300-y.
p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis.
Li M, Yang J, Liu K, Yang J, Zhan X, Wang L
J Cancer. 2020; 11(6):1457-1467.
PMID: 32047552
PMC: 6995400.
DOI: 10.7150/jca.35479.
Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
Wang Y, Ma J, Qiu W, Zhang J, Feng S, Zhou X
Int J Mol Sci. 2018; 19(9).
PMID: 30235878
PMC: 6163908.
DOI: 10.3390/ijms19092837.
Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer.
Yabasin I, Sanches J, Ibrahim M, Huidan J, Williams W, Lu Z
Front Physiol. 2018; 9:941.
PMID: 30108509
PMC: 6079220.
DOI: 10.3389/fphys.2018.00941.
A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets.
Lang P, Gershon T
Bioessays. 2018; 40(5):e1700243.
PMID: 29577351
PMC: 5910257.
DOI: 10.1002/bies.201700243.
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N
Nature. 2017; 553(7686):91-95.
PMID: 29160310
PMC: 5754234.
DOI: 10.1038/nature25015.
miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
Lang B, Zhao S
Oncol Rep. 2017; 39(1):71-80.
PMID: 29115564
PMC: 5783606.
DOI: 10.3892/or.2017.6064.
Effects of bisphenol compounds on the growth and epithelial mesenchymal transition of MCF-7 CV human breast cancer cells.
Kim J, Choi H, Lee H, Lee G, Hwang K, Choi K
J Biomed Res. 2017; 31(4):358-369.
PMID: 28808208
PMC: 5548997.
DOI: 10.7555/JBR.31.20160162.
LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
Zhang H, Zhang J, Hao C, Zhou Y, Wang J, Cheng M
Am J Transl Res. 2017; 9(6):2736-2747.
PMID: 28670365
PMC: 5489877.